Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Fri 17 Aug 2007, 14:00 ENL - Enaleni Pharmaceuticals Announces Changes To
ENL
 ENL                                                                             
ENL - Enaleni Pharmaceuticals Announces Changes To Board Of Directors           
Enaleni Pharmaceuticals Limited                                                 
(Incorporated in the Republic of South Africa)                                  
(Registration number 2002/018027/06)                                            
JSE code: ENL & ISIN: ZAE000067740                                              
("Enaleni")                                                                     
Enaleni Pharmaceuticals announces changes to Board of Directors                 
Shareholders are advised as follows:                                            
Resignations:                                                                   
Having completed the handover of the pharmaceutical business to incoming CEO    
Jerome Smith and with the sale of the Consumer and Vitality Division businesses 
progressing according to plan, Trevor Edwards, Joint CEO, who in June 2007      
announced his retirement from the business, has resigned from the board with    
effect from 17 August 2007.                                                     
Andrew Hall, the Enaleni CFO, has resigned from the board with effect from 17   
August 2007 due to family reasons and a decision to return to Johannesburg. The 
appointment of a replacement for Mr Hall is well progressed and will be         
announced in due course.                                                        
New appointments:                                                               
The Board has appointed Mr Chris Aucamp as Commercial Director with effect from 
17 August 2007. Mr Aucamp, a chartered accountant, has been the financial       
director of Cipla Medpro for 11 years and has substantial knowledge of the      
pharmaceutical industry. Mr Aucamp will also oversee the CFO function of the    
Enaleni group until such time as a replacement for Mr Hall is announced.        
Durban                                                                          
17 August 2007                                                                  
Sponsor                                                                         
Nedbank Capital                                                                 
Date: 17/08/2007 14:00:01 Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.                                          
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: